{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:50:00Z","timestamp":1789026600891,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.canrad.2025.104593","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T12:52:33Z","timestamp":1741697553000},"page":"104593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Moderate versus ultra-hypofractionated locoregional breast radiotherapy: Results of a retrospective study during the covid-19 era"],"prefix":"10.1016","volume":"29","author":[{"given":"Paola Andrea","family":"Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Emmanuella","family":"Y\u00e9o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Dh\u00e9nin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00e9onore","family":"Brahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julinne","family":"Stokart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Donnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Seret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Vanderick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Bihin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"R\u00e9gnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Remouchamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.canrad.2025.104593_bib0150","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.canrad.2025.104593_bib0155","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I\u2013III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans","year":"2020","journal-title":"Lancet Oncol"},{"issue":"9503","key":"10.1016\/j.canrad.2025.104593_bib0160","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials","volume":"366","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.canrad.2025.104593_bib0165","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/djh297","article-title":"Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial","volume":"97","author":"Ragaz","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"10416","key":"10.1016\/j.canrad.2025.104593_bib0170","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(23)01082-6","article-title":"Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials","volume":"402","author":"Taylor","year":"2023","journal-title":"Lancet"},{"issue":"36","key":"10.1016\/j.canrad.2025.104593_bib0175","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1200\/JCO.22.00044","article-title":"Internal mammary node irradiation in patients with node-positive early breast cancer: fifteen-year results from the Danish Breast Cancer Group Internal Mammary Node Study","volume":"40","author":"Thorsen","year":"2022","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.canrad.2025.104593_bib0180","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2025.104593_bib0185","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2025.104593_bib0190","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.breast.2020.12.010","article-title":"Why is appropriate healthcare inaccessible for many European breast cancer patients?.\u2013The EBCC 12 manifesto","volume":"55","author":"Cardoso","year":"2021","journal-title":"Breast"},{"issue":"9","key":"10.1016\/j.canrad.2025.104593_bib0195","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1016\/j.clon.2022.05.019","article-title":"Change in the use of fractionation in radiotherapy used for early breast cancer at the start of the covid-19 pandemic: a population-based cohort study of older women in England and Wales","volume":"34","author":"Gannon","year":"2022","journal-title":"Clin Oncol"},{"issue":"10237","key":"10.1016\/j.canrad.2025.104593_bib0200","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"issue":"28","key":"10.1016\/j.canrad.2025.104593_bib0205","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1200\/JCO.19.02750","article-title":"Ten-year results of FAST: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer","volume":"38","author":"Brunt","year":"2020","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.canrad.2025.104593_bib0210","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104593_bib0215","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S1470-2045(21)00539-8","article-title":"European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer","volume":"23","author":"Meattini","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2025.104593_bib0220","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S0167-8140(22)02477-X","article-title":"OC-0101 First results of FAST-Forward phase 3 RCT nodal substudy: 3-year normal tissue effects","volume":"170","author":"Wheatley","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104593_bib0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.breast.2020.12.009","article-title":"Acute toxicity and health-related quality of life after accelerated whole breast irradiation in 5 fractions with simultaneous integrated boost","volume":"55","author":"Van Hulle","year":"2021","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.canrad.2025.104593_bib0230","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijrobp.2008.11.005","article-title":"Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy","volume":"75","author":"Kirova","year":"2009","journal-title":"Int J Radiat Oncol"},{"issue":"8","key":"10.1016\/j.canrad.2025.104593_bib0235","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"Von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.canrad.2025.104593_bib0240","series-title":"Appendix 1 to the guideline on the evaluation of anticancer medicinal products in man","author":"Anon","year":"2012"},{"key":"10.1016\/j.canrad.2025.104593_bib0245","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) v4. 0","author":"Anon","year":"2010"},{"issue":"2","key":"10.1016\/j.canrad.2025.104593_bib0250","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.canrad.2025.104593_bib0255","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"3","key":"10.1016\/j.canrad.2025.104593_bib0260","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10549-010-0898-8","article-title":"Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients","volume":"124","author":"Bastiaannet","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.canrad.2025.104593_bib0265","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1371\/journal.pmed.0030025","article-title":"Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden","volume":"3","author":"Eaker","year":"2006","journal-title":"PLoS Med"},{"issue":"6.","key":"10.1016\/j.canrad.2025.104593_bib0270","article-title":"Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor\u2013positive breast cancer","volume":"307","author":"van de Water","year":"2012","journal-title":"JAMA"},{"issue":"S1","key":"10.1016\/j.canrad.2025.104593_bib0275","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.21037\/tcr.2019.08.28","article-title":"Radiotherapy in elderly patients with breast cancer: a literature review of acute and late toxicity","volume":"9","author":"Zamagni","year":"2020","journal-title":"Transl Cancer Res"},{"issue":"1","key":"10.1016\/j.canrad.2025.104593_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2006.01.007","article-title":"Introduction to clinical radiation biology","volume":"20","author":"Willers","year":"2006","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"10.1016\/j.canrad.2025.104593_bib0285","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.hoc.2019.07.001","article-title":"Toward a new framework for clinical radiation biology","volume":"33","author":"Willers","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.canrad.2025.104593_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/WWBF1044","article-title":"One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT","volume":"27","author":"Brunt","year":"2023","journal-title":"Health Technol Assess"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825000095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825000095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T01:58:25Z","timestamp":1744423105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321825000095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1278321825000095"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104593","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moderate versus ultra-hypofractionated locoregional breast radiotherapy: Results of a retrospective study during the covid-19 era","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104593"}}